Everolimus Prolongs Progression-Free...
Combination Treatment with Octreotide Shows Improved Results in Tumors Associated with Carcinoid Syndrome
MD Anderson News Release 11/29/11
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The...
MD Anderson Cancer Center Board of Visitors Welcomes New Members
Incoming 16 Will Join Efforts to Support Institution's Mission to Eradicate Cancer
MD Anderson News Release 11/28/...
UT MD Anderson Creates Institute to Accelerate Cancer Drug...
Organization focuses academic, private sector strengths on process in dire need of improvement
MD Anderson News Release...
Tamoxifen Causes Significant Side Effects...
Many Men Discontinue Treatment, Increasing Their Chances for Recurrence
MD Anderson News Release 11/16/11
PODCAST: Listen to Dr. Sharon Giordanodiscuss male breast cancer, a disease
that is rare but increasing in incidence.
About half of male breast cancer patients who take the drug tamoxifen to prevent their disease from returning report side effects such as weight gain and sexual dysfunction, which...
UT MD Anderson Slates San Antonio A Conversation With a Living...
Luncheon Honoring Cokie Roberts, Sam Donaldson Benefits Cancer Research, Patient Care
MD Anderson News Release 11/11/11...
UT MD Anderson Study Finds Acupuncture Can Prevent...
Obese Monkeys Lose Weight on Drug that Attacks Blood Supply of Fat...
Targeted approach provides a new avenue for potential anti-obesity medication
MD Anderson News Release 11/9/11
...
UT MD Anderson Study Finds Advances in Breast Cancer Don't Extend...
Implications seen for fastest growing segment of cancer population
MD Anderson News Release 11/07/11
The survival...
Infographic: How to Carve Up Thanksgiving Calories
UT MD Anderson experts share portion control Thanksgiving infographic
MD Anderson News Release 11/07/11
Adults...
Metabolic Protein Plays Unexpected Role in Tumor Cell Formation...
Findings point to possible personalized brain tumor therapy with Src inhibitors
MD Anderson News Release 11/06/11...